Trials / Completed
CompletedNCT03045926
Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea
Assessment of Elemental Impurities Level After Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to assess the concentration of elemental impurities in blood and urine after chronic administration of Smecta® in subjects with chronic functional diarrhoea. For exploratory purposes, the potential effects of diosmectite on bowel microbiote composition will be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diosmectite (Smecta®) |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-05-09
- Completion
- 2017-05-09
- First posted
- 2017-02-08
- Last updated
- 2019-04-05
- Results posted
- 2019-03-11
Locations
2 sites across 2 countries: Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT03045926. Inclusion in this directory is not an endorsement.